-
Je něco špatně v tomto záznamu ?
Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy
I. Brezaniova, M. Hruby, J. Kralova, V. Kral, Z. Cernochova, P. Cernoch, M. Slouf, J. Kredatusova, P. Stepanek,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- experimentální nádory mléčných žláz terapie MeSH
- fotochemoterapie metody MeSH
- fotosenzibilizující látky aplikace a dávkování terapeutické užití MeSH
- lidé MeSH
- lipidy chemie MeSH
- mastné alkoholy aplikace a dávkování terapeutické užití MeSH
- mesoporfyriny chemie MeSH
- myši nahé MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- nanočástice chemie MeSH
- nosiče léků chemie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
We developed fully biodegradable/metabolizable nanosystem based on polymer surfactant-stabilized thermoresponsive solid lipid nanoparticles with non-covalently bound photosensitizer temoporfin (T-SLNP) with particle size below 50nm. The efficacy of T-SLNP was compared with commercial temoporfin formulation in terms of in vitro phototoxicity in 4T1 (murine mammary carcinoma) and MDA-MB-231(human breast adenocarcinoma) cells and of in vivo anticancer effect in Nu/Nu mice bearing MDA-MB-231 tumors. In vitro study demonstrated faster accumulation kinetics in the cells for our formulation design resulting in higher phototoxicity against the tumor cells. In vivo anticancer efficacy was markedly improved by T-SLNP compared with commercial temoporfin formulation. Owing to controlled and sustained release properties, subcellular size, biocompatibility with tissue and cells, the T-SLNP nanodispersion prepared in this study represents promising drug delivery system applicable in cancer treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010989
- 003
- CZ-PrNML
- 005
- 20180404142445.0
- 007
- ta
- 008
- 180404s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jconrel.2016.09.009 $2 doi
- 035 __
- $a (PubMed)27622757
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Brezaniova, Ingrid $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague 6, Czech Republic.
- 245 10
- $a Temoporfin-loaded 1-tetradecanol-based thermoresponsive solid lipid nanoparticles for photodynamic therapy / $c I. Brezaniova, M. Hruby, J. Kralova, V. Kral, Z. Cernochova, P. Cernoch, M. Slouf, J. Kredatusova, P. Stepanek,
- 520 9_
- $a We developed fully biodegradable/metabolizable nanosystem based on polymer surfactant-stabilized thermoresponsive solid lipid nanoparticles with non-covalently bound photosensitizer temoporfin (T-SLNP) with particle size below 50nm. The efficacy of T-SLNP was compared with commercial temoporfin formulation in terms of in vitro phototoxicity in 4T1 (murine mammary carcinoma) and MDA-MB-231(human breast adenocarcinoma) cells and of in vivo anticancer effect in Nu/Nu mice bearing MDA-MB-231 tumors. In vitro study demonstrated faster accumulation kinetics in the cells for our formulation design resulting in higher phototoxicity against the tumor cells. In vivo anticancer efficacy was markedly improved by T-SLNP compared with commercial temoporfin formulation. Owing to controlled and sustained release properties, subcellular size, biocompatibility with tissue and cells, the T-SLNP nanodispersion prepared in this study represents promising drug delivery system applicable in cancer treatment.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a mastné alkoholy $x aplikace a dávkování $x terapeutické užití $7 D005233
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lipidy $x chemie $7 D008055
- 650 _2
- $a experimentální nádory mléčných žláz $x terapie $7 D008325
- 650 _2
- $a mesoporfyriny $x chemie $7 D008652
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a fotochemoterapie $x metody $7 D010778
- 650 _2
- $a fotosenzibilizující látky $x aplikace a dávkování $x terapeutické užití $7 D017319
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hruby, Martin $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, v.v.i, Heyrovskéhonám. 2, 162 06 Prague 6, Czech Republic. Electronic address: mhruby@centrum.cz.
- 700 1_
- $a Kralova, Jarmila $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videňská 1083, 142 20 Prague 4, Czech Republic.
- 700 1_
- $a Kral, Vladimir $u Faculty of Chemical Engineering, University of Chemistry and Technology Prague, Technická 5, 166 28 Prague 6, Czech Republic.
- 700 1_
- $a Cernochova, Zulfiya $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, v.v.i, Heyrovskéhonám. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Cernoch, Peter $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, v.v.i, Heyrovskéhonám. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Slouf, Miroslav $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, v.v.i, Heyrovskéhonám. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Kredatusova, Jana $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, v.v.i, Heyrovskéhonám. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Stepanek, Petr $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, v.v.i, Heyrovskéhonám. 2, 162 06 Prague 6, Czech Republic.
- 773 0_
- $w MED00002621 $t Journal of controlled release official journal of the Controlled Release Society $x 1873-4995 $g Roč. 241, č. - (2016), s. 34-44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27622757 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180404142524 $b ABA008
- 999 __
- $a ok $b bmc $g 1288474 $s 1007801
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 241 $c - $d 34-44 $e 20160910 $i 1873-4995 $m Journal of controlled release $n J Controlled Release $x MED00002621
- LZP __
- $a Pubmed-20180404